Back to top

Children's National - NIAID Partnership

 

This annual symposium celebrates the partnership between Children’s National Hospital (CNH) and the National Institute of Allergy and Infectious Diseases (NIAID). Established in 2017, the CNH-NIAID partnership focuses on advancing the health of children with allergic, immunologic, and infectious diseases through collaborative research and education.

This year, the Symposium will be held on Thursday, June 3rd and Friday, June 4th as a virtual event that highlights current research on COVID-19 and multisystem inflammatory syndrome in children (MIS-C), and the intersectionality of COVID-19, allergy, and immunology on the pediatric population. Keynote speaker pediatric neurologist and 73rd Governor of The Commonwealth of Virginia, Ralph Northam, will talk on the COVID-19 pandemic and strategies to reintroduce children into schools and sports.  

Questions? Contact us at CN-NIAIDPartnership@childrensnational.org

 

4th Annual children's national HOSPITAL - niaid Virtual symposium

 

AGENDA: 

Thursday, June 3, 2021

12:00      Welcome: Mark Batshaw, MD (Children's National Hospital) 

 

12:00 - 1:20 pm     Clinical Manifestations of SARS-CoV-2 in Children

Moderator: Roberta L. DeBiasi, MD, MS (Children’s National Hospital)

12:00 - 12:20 pm                                   
Cardiac Manifestations of COVID-19 in Children

Anita Krishnan, MD (Children's National Hospital)



12:20 - 12:40 pm                                   
Immunomodulation and Cytokine Profiling in 
MIS-C 
Hemalatha Srinivasalu, MD (Children's National Hospital)

12:40 - 1:00 pm
The MUSIC study:  Long-TerM OUtcomes After the Multisystem Inflammatory Syndrome In Children
Jane Newburger, MD, MPH (Boston Children's Hospital)

1:00 - 1:20 pm
Q&A

1:20 - 1:30 pm     Break

 

1:30 - 2:50 pm     Comparative Disease Biology (Comparing Children and Adult Manifestations)

Moderator: Catherine Bollard, MD, MBChB (Children's National Hospital)

1:30 - 1:50 pm
MIS-C in Typical Cases and Down Syndrome
Dusan Bogunovic, PhD (Icahn School of Medicine at Mount Sinai)

1:50 - 2:10 pm
Age-Related Virus-Specific T Cell Responses to SARS-CoV-2
Susan Conway, MD (Children’s National Hospital)

2:10 - 2:30 pm
Do Differences Make a Difference: Integrating Human Population and Single Cell Variations in Health and Disease
John S. Tsang, PhD (NIAID)

2:30 - 2:50 pm
Q&A

2​​​:50 - 3:00     Break

 

3​​​:00 - 4:20 pm     COVID-19 Therapies and Vaccines in the Pediatric Setting

Moderator: Gina Montealegre, MD (NIAID)

3​​​:00 - 3:20 pm
Therapeutics for Children with COVID-19: Trying to be Data Driven in the Absence of Pediatric Trials
Andrew T. Pavia, MD (University of Utah Health)

3​​​:20 - 3:40 pm
SARS-CoV-2 Vaccine Clinical Research
Alicia Widge, MD, MPH (NIAID)

3​​​:40 - 4:00 pm
COVID-19 Vaccine Distribution: Keeping Our Focus on Equity
Cara Biddle, MD, MPH (Children’s National Hospital)

4​​​:00 - 4:20 pm
Q&A

4:20 - 4:30 pm     Break

 

4:30 - 5:00 pm     The Covid-19 Pandemic: Reintroducing Children into Schools and Sports

Moderator: Kurt Newman, MD (Children's National Hospital)                      
Keynote Speaker: Virginia Governor Ralph Northam 

 

Friday, June 4, 2021

10:00 - 11:20 am     Intersectionality of Allergy, Immunology, and COVID-19

Moderator: Luigi D. Notarangelo, MD (NIAID)

10:00 - 10:20 am
COVID-19 and Pediatric Asthma
William Sheehan, MD (Children’s National Hospital)

10:20 - 10:40 am
The COVID-19 Pandemic and Immunodeficiency: The Burden and Emerging Evidence
Jessica Durkee-Shock, MD (NIAID)

10:40 - 11:00 am
SARS-CoV2 Infection in Children with Cancer: The MSK Experience
Andrew Kung, MD, PhD (Memorial Sloan Kettering Cancer Center)

11:00 - 11:20 am
Q&A 

11:20 - 11:30 am     Break
 

 

11:30 am - 12:50 pm     Modulating Biologic Factors in Immune Regulation

Moderator: Michael Keller, MD (Children's National Hospital)

11:30 - 11:50 am
Adaptive and Maladaptive Immunity to the Microbiota: Implication for Inflammatory Disorders
Yasmine Belkaid, PhD (NIAID)

11:50 am - 12:10 pm
Deep Immune Profiling of Peanut Reactive CD4+ T Cells Reveals Distinct Immunotypes Link to Clinical Outcome
Erik Wambre, PhD (Benaroya Research Institute)

12:10 - 12:30 pm
B Cells and Food Allergy: Not Just for Making IgE
Adora Lin, MD, PhD (Children's National Hospital)

12:30 - 12:50 pm
Q&A

12:50 - 1:00 pm     Break

 

1:00 - 2:20 pm     Treatments that Invoke Tolerance in Allergy

Moderator: Jonathan J. Lyons, MD (NIAID)

1:00 - 1:20 pm 
Emerging Biologic Therapies for Food Allergy

Hemant Sharma, MD, MHS (Children's National Hospital)

1:20 - 1:40 pm 
The Promise and Limits of Allergen Immunotherapy  
Carla M. Davis, MD (Texas Children's Hospital)

1:40 - 2:00 pm 
Maternal Fetal Interactions in Food Tolerance
Michiko K. Oyoshi, MD (Harvard Medical School)

2:00 - 2:20 pm 
Q&A

 

2:20 - 2:30 pm     Closing Remarks: H. Clifford Lane, MD (NIAID)


All times listed are in the Eastern timezone.

                            

SPEAKERS:

 

 

 

 

 

 

 

 

                

about the partnership

In 2017, The National Institute of Allergy and Infectious Diseases (NIAID) and Children’s National Hospital launched a clinical research partnership devoted to protecting and advancing the health of children with allergic, immunologic, auto-inflammatory, and infectious disease through collaborative research and education. This strategic and novel alliance is supported through the Clinical and Translational Science Institute at Children’s National (CTSI-CN). The partnership, co-led by H. Clifford Lane, M.D., Deputy Director for Clinical Research and Special Projects at NIAID, and Mark Batshaw, M.D., Executive Vice President and Chief Academic Officer at Children’s National, holds the mission to generate and apply knowledge to promote the prevention, diagnosis, treatment, and cure of these childhood diseases through its work together.

For each area, designated investigators from each institution are collaborating to design and conduct clinical research studies that will advance prevention strategies, diagnoses, treatments, and cures for the diverse range of pediatric diseases involving the immune system. Many of these studies will include children at high risk for complications related to their underlying disease or to experimental therapeutics and diagnostic tests they receive. Research participants will have the opportunity to be seen at both Children’s National and the NIH Clinical Center in Bethesda, Maryland. Together, the two institutions provide comprehensive, state-of-the-art pediatric clinical support, infrastructure, and research capacity. These resources protect the safety of children, ensure that they receive the highest quality of care, and offer them the opportunity to participate in cutting-edge clinical research. In addition, the partnership established joint training opportunities for physician-scientists interested in caring for these children while developing their research expertise in pediatric immunology, allergic, and infectious diseases.

The collaboration is supported through an NIAID supplement to the Clinical and Translational Science Institute at Children's National, which is funded by a Clinical and Translational Science Award from NIH’s National Center for Advancing Translational Sciences to Children’s National Hospital and The George Washington University.

 

projects

leadership

GOVERNING BOARD:

EXECUTIVE STEERING COMMITTEE:

PROGRAM DIRECTOR:

OPERATIONS:

 

partners

Children’s National Hospital - Children’s National, based in Washington, D.C., has served the nation’s children since 1870. Children’s National is one of the nation’s Top 5 pediatric hospitals and, for a second straight year, is ranked No. 1 in newborn care, as well as ranked in all specialties evaluated by U.S. News & World Report. It has been designated two times as a Magnet® hospital, a designation given to hospitals that demonstrate the highest standards of nursing and patient care delivery. This pediatric academic health system offers expert care through a convenient, community-based primary care network and specialty outpatient centers in the D.C. Metropolitan area, including the Maryland suburbs and Northern Virginia. Home to the Children’s Research Institute and the Sheikh Zayed Institute for Pediatric Surgical Innovation, Children’s National is the seventh-highest NIH-funded pediatric institution in the nation. Children’s National is recognized for its expertise and innovation in pediatric care and as a strong voice for children through advocacy at the local, regional and national levels. 

National Institute of Allergy and Infectious Diseases (NIAID) - NIAID conducts and supports research—at NIH, throughout the United States, and worldwideto study the causes of infectious and immune-mediated diseases, and to develop better means of preventing, diagnosing and treating these illnesses. Visit NIAID for news releases, fact sheets and other NIAID-related materials.

 

past symposiumS

  •  

  September 18, 2018: Inaugural CN-NIAID Symposium

 

 

 

 

 

 

 

  November 8, 2019: 2nd CN-NIAID Symposium

 

 

 

 

 


  September 29, 2020: 3rd CNH-NIAID Symposium
  
  View recordings